BREXOGEN
Latest round
- Series C
Last raised
- Sep 2023
Total raised
- $24M
Investors
- 10
About BREXOGEN
Founded in 2019 and based in Seoul, South Korea, BREXOGEN operates as a pharmaceutical company that researches and develops new exosome-based medicine. It will be used for non-clinical research and production costs of clinical trial drugs for entry into phase 1 clinical trials of MI01).
Who invested in BREXOGEN
10 investors across 3 rounds
See all investors in BREXOGEN
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about BREXOGEN
Who invested in BREXOGEN?
BREXOGEN has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BREXOGEN raised?
BREXOGEN has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did BREXOGEN last raise money?
BREXOGEN's most recent round on record is a Series C, in Sep 2023.
What does BREXOGEN do?
Founded in 2019 and based in Seoul, South Korea, BREXOGEN operates as a pharmaceutical company that researches and develops new exosome-based medicine.
Where is BREXOGEN headquartered?
BREXOGEN is headquartered in Seoul, South Korea.
Which VCs invest in companies like BREXOGEN?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at BREXOGEN's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like BREXOGEN? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.